SG10201508591UA - Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate - Google Patents
Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitateInfo
- Publication number
- SG10201508591UA SG10201508591UA SG10201508591UA SG10201508591UA SG10201508591UA SG 10201508591U A SG10201508591U A SG 10201508591UA SG 10201508591U A SG10201508591U A SG 10201508591UA SG 10201508591U A SG10201508591U A SG 10201508591UA SG 10201508591U A SG10201508591U A SG 10201508591UA
- Authority
- SG
- Singapore
- Prior art keywords
- diquafosol
- producing
- same
- ophthalmic solution
- insoluble precipitate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7084—Compounds having two nucleosides or nucleotides, e.g. nicotinamide-adenine dinucleotide, flavine-adenine dinucleotide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Ophthalmology & Optometry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010291463 | 2010-12-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201508591UA true SG10201508591UA (en) | 2015-11-27 |
Family
ID=46383087
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201508591UA SG10201508591UA (en) | 2010-12-28 | 2011-12-27 | Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate |
| SG2013050000A SG191389A1 (en) | 2010-12-28 | 2011-12-27 | Ophthalmic solution containing diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG2013050000A SG191389A1 (en) | 2010-12-28 | 2011-12-27 | Ophthalmic solution containing diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20140221306A1 (fr) |
| EP (1) | EP2659894A4 (fr) |
| JP (1) | JP2012149057A (fr) |
| KR (1) | KR20140003493A (fr) |
| CN (1) | CN103282039A (fr) |
| AU (1) | AU2011350762B2 (fr) |
| BR (1) | BR112013016008B1 (fr) |
| CA (1) | CA2823148A1 (fr) |
| EA (1) | EA027736B1 (fr) |
| GE (1) | GEP20166448B (fr) |
| MX (1) | MX2013007502A (fr) |
| MY (1) | MY161032A (fr) |
| SG (2) | SG10201508591UA (fr) |
| TW (1) | TW201306844A (fr) |
| UA (1) | UA113839C2 (fr) |
| WO (1) | WO2012090994A1 (fr) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3431092A1 (fr) * | 2012-03-26 | 2019-01-23 | Santen Pharmaceutical Co., Ltd. | Solution ophtalmique comprenant du diquafosol |
| BR112017013841A2 (pt) * | 2014-12-25 | 2018-06-19 | Santen Pharmaceutical Co., Ltd. | solução oftálmica aquosa |
| RU2742032C2 (ru) | 2015-06-05 | 2021-02-01 | Сантен Фармасьютикал Ко., Лтд. | Терапевтическое средство против сухости глаз, характеризуемое нанесением на глаза пациентов с сухостью глаз, носящих гибкие контактные линзы |
| CN117137866A (zh) * | 2018-02-28 | 2023-12-01 | 参天制药株式会社 | 含有地夸磷索及阳离子性聚合物的眼科用组合物 |
| CN108853016A (zh) * | 2018-09-26 | 2018-11-23 | 广州大光制药有限公司 | 一种地夸磷索钠滴眼液及其制备方法 |
| US20220054520A1 (en) * | 2019-02-27 | 2022-02-24 | Santen Pharmaceutical Co., Ltd. | Ophthalmic composition containing diquafosol or salt thereof, vinyl-based polymer and cellulose-based polymer |
| KR102656181B1 (ko) * | 2019-08-27 | 2024-04-08 | 산텐 세이야꾸 가부시키가이샤 | 디쿠아포솔 또는 그 염 및 폴리비닐피롤리돈을 함유하는 수성 안과용 조성물 |
| JP7230169B2 (ja) * | 2020-12-25 | 2023-02-28 | 参天製薬株式会社 | ジクアホソルまたはその塩、銀塩およびイオン性等張化剤を含有する水性点眼液 |
| CN113712910A (zh) * | 2021-08-05 | 2021-11-30 | 广州市桐晖药业有限公司 | 一种滴眼液及其制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5900407A (en) * | 1997-02-06 | 1999-05-04 | Inspire Pharmaceuticals, Inc. | Method of treating dry eye disease with uridine triphosphates and related compounds |
| NZ501696A (en) | 1997-07-25 | 2001-08-31 | Inspire Pharmaceuticals Inc | Method for large-scale production of sodium and ammonium salts of di(uridine 5')-tetraphosphate |
| JP4003008B2 (ja) * | 2000-05-30 | 2007-11-07 | 参天製薬株式会社 | 角膜上皮伸展促進剤 |
| WO2001091795A1 (fr) * | 2000-05-30 | 2001-12-06 | Santen Pharmaceutical Co., Ltd. | Promoteurs de l'extension de l'epithelium corneen |
| JP2003160491A (ja) * | 2001-09-11 | 2003-06-03 | Santen Pharmaceut Co Ltd | ジウリジンリン酸含有点眼液 |
| JP4168071B2 (ja) | 2005-12-08 | 2008-10-22 | 興和株式会社 | 点眼用組成物 |
| AU2011299851A1 (en) * | 2010-09-10 | 2013-04-04 | Santen Pharmaceutical Co., Ltd. | Agent for treatment of dry eye characterized by combining P2Y2 receptor agonist with hyaluronic acid or salt thereof, method for treating dry eye, and use of the P2Y2 receptor agonist and hyaluronic acid or salt thereof |
-
2011
- 2011-12-27 EA EA201390985A patent/EA027736B1/ru unknown
- 2011-12-27 CN CN2011800632699A patent/CN103282039A/zh active Pending
- 2011-12-27 SG SG10201508591UA patent/SG10201508591UA/en unknown
- 2011-12-27 MX MX2013007502A patent/MX2013007502A/es unknown
- 2011-12-27 UA UAA201309390A patent/UA113839C2/uk unknown
- 2011-12-27 WO PCT/JP2011/080179 patent/WO2012090994A1/fr active Application Filing
- 2011-12-27 SG SG2013050000A patent/SG191389A1/en unknown
- 2011-12-27 AU AU2011350762A patent/AU2011350762B2/en not_active Ceased
- 2011-12-27 BR BR112013016008-0A patent/BR112013016008B1/pt not_active IP Right Cessation
- 2011-12-27 GE GEAP201113176A patent/GEP20166448B/en unknown
- 2011-12-27 US US13/976,408 patent/US20140221306A1/en not_active Abandoned
- 2011-12-27 TW TW100148759A patent/TW201306844A/zh unknown
- 2011-12-27 CA CA2823148A patent/CA2823148A1/fr not_active Abandoned
- 2011-12-27 JP JP2011285977A patent/JP2012149057A/ja not_active Withdrawn
- 2011-12-27 MY MYPI2013002461A patent/MY161032A/en unknown
- 2011-12-27 KR KR1020137019146A patent/KR20140003493A/ko not_active Application Discontinuation
- 2011-12-27 EP EP11852288.7A patent/EP2659894A4/fr not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| UA113839C2 (xx) | 2017-03-27 |
| SG191389A1 (en) | 2013-07-31 |
| WO2012090994A1 (fr) | 2012-07-05 |
| BR112013016008B1 (pt) | 2021-06-29 |
| EP2659894A4 (fr) | 2014-12-10 |
| MY161032A (en) | 2017-04-03 |
| CA2823148A1 (fr) | 2012-07-05 |
| TW201306844A (zh) | 2013-02-16 |
| EA027736B1 (ru) | 2017-08-31 |
| JP2012149057A (ja) | 2012-08-09 |
| EA201390985A1 (ru) | 2013-11-29 |
| BR112013016008A2 (pt) | 2018-07-10 |
| KR20140003493A (ko) | 2014-01-09 |
| GEP20166448B (en) | 2016-03-25 |
| AU2011350762A1 (en) | 2013-07-25 |
| EP2659894A1 (fr) | 2013-11-06 |
| CN103282039A (zh) | 2013-09-04 |
| MX2013007502A (es) | 2013-08-01 |
| US20140221306A1 (en) | 2014-08-07 |
| AU2011350762B2 (en) | 2017-04-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG10201508591UA (en) | Ophthalmic solution comprising diquafosol, method for producing the same, and method for inhibiting formation of insoluble precipitate | |
| IL269322B (en) | Methylphenidate-medications, processes for their preparation and use | |
| HK1248214A1 (zh) | 新噻吩並嘧啶衍生物、其製備方法及其治療用途 | |
| HK1200879A1 (en) | Magnesium-aluminum-zinc alloy, method for the production thereof and use thereof | |
| HK1203073A1 (en) | Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same | |
| SG11201502284UA (en) | Method of producing a tube for use in the formation of a stent, and such tube | |
| PL2678035T3 (pl) | Pochodne fenalen-1-onu, sposób ich wytwarzania i zastosowanie | |
| EP2537867A4 (fr) | Acide hyaluronique modifié et/ou sel de celui-ci, procédé de production associé et produit cosmétique le comprenant | |
| GB2509677B (en) | Method for producing medical oversleeves and production system | |
| PT2810599T (pt) | Sistema de estimulação elétrica para o tratamento da apneia do sono | |
| HK1193693A1 (zh) | 連接方法、連接體的製造方法以及連接體 | |
| EP2860050A4 (fr) | Structure d'accouplement, élément d'accouplement ayant une structure d'accouplement et procédé pour produire un élément d'accouplement ayant une structure d'accouplement | |
| HK1182656A1 (zh) | 帶藥劑的支承體及其製造方法 | |
| PL2723743T3 (pl) | Pochodne 10H-benzo[g]pterydyno-2,4-dionu, sposób ich wytwarzania i ich zastosowanie | |
| IL231677A0 (en) | A crystal of 5-hydroxy-1h-imidazole-4-carboxamide 4/3 hydrate, a method for its production and a crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate | |
| GB2514255B (en) | Laminating system, laminating pouch, and method of manufacture | |
| EP2729926A4 (fr) | Système et procédé d'administration d'évaluation sans fil | |
| EP2881137A4 (fr) | Instrument médical et procédé de production d'un instrument médical | |
| EP2851359A4 (fr) | Procédé de fabrication de 4,4"-dihidroxy-m-terphényles | |
| PL2723742T3 (pl) | Pochodne 10H-benzo[g]pterydyno-2,4-dionu, sposób ich wytwarzania i zastosowanie | |
| EP2913067A4 (fr) | Vaisseau sanguin artificiel, et procédé de production d'un vaisseau sanguin artificiel | |
| EP2885014B8 (fr) | Implant et procédé de fabrication correspondant | |
| PL391832A1 (pl) | Sole N-triazynyloamoniowe, sposób ich wytwarzania oraz ich zastosowanie | |
| ZA201402327B (en) | Crystal of 5-hydroxy-1h-imidazole-4-carboxamide.3/4 hydrate,method for producing the same and crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate | |
| EP2939694A4 (fr) | Agent de dialyse, et procédé de production d'agent de dialyse |